Ledger.Open graph →
SEC Form D · Amendment · filed November 6, 2020

Blue Lake Biotechnology, Inc

Offering
$8.8M
Sold
$8.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ATHENS, GA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Biao He · Athens, GAExec · Director · PromoterFred Quinn · Athens, GADirectorJixiang An · Athens, GADirectorYuan Lin · Athens, GADirectorJi Ma · Athens, GADirectorVicky Schiff · Calabasas, CADirectorBradley Zucker · Cleveland, OHDirectorAdrian Dzielnicki · Boca Raton, FLExec · Director · PromoterBrett M. Slattery · Gainesville, GADirectorWojciech Gudaszewski · Boca Raton, FLDirectorKory Cash · Grants, NMDirectorBryan Campo · Gilbert, AZDirectorTodd Cash · Gilbert, AZDirectorDean Stathakis · Huntington Beach, CAExec · Director · PromoterGerald Birch · Huntington Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗